Calithera Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018	2017 - 2012
Net Income	-18.87	-165.34	-88.52	-86.35	-51.47	Upgrade
Depreciation & Amortization	0.26	0.28	0.36	0.48	0.51	Upgrade
Share-Based Compensation	4.03	10.26	8.06	6.47	0	Upgrade
Other Operating Activities	-29.03	88.49	-4.21	0.66	-13.88	Upgrade
Operating Cash Flow	-43.61	-66.3	-84.31	-78.75	-64.84	Upgrade
Capital Expenditures	-0.13	-0.15	-0.06	-0.01	-0.21	Upgrade
Change in Investments	-	-8	-203.14	-295.68	-205.23	Upgrade
Other Investing Activities	-	16	292.16	284.9	258.24	Upgrade
Investing Cash Flow	-0.13	7.85	88.96	-10.78	52.8	Upgrade
Common Stock Issued	9.64	10.66	40.86	97.69	13.71	Upgrade
Other Financing Activities	0.02	0	1.2	1.22	0.92	Upgrade
Financing Cash Flow	9.66	10.67	42.06	98.91	14.63	Upgrade
Net Cash Flow	-34.09	-47.78	46.71	9.38	2.58	Upgrade
Free Cash Flow	-43.74	-66.45	-84.37	-78.75	-65.06	Upgrade
Free Cash Flow Margin	-	-681.51%	-	-	-292.33%	Upgrade
Free Cash Flow Per Share	-8.76	-17.99	-24.52	-33.29	-35.55	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.